What is the differential diagnosis and recommended workup for a burning/heat sensation affecting the soles, palms, and scalp?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Heat Sensation in Soles, Palms, and Scalp

This symptom pattern strongly suggests small fiber neuropathy, most commonly diabetic peripheral neuropathy, and requires immediate screening for diabetes and other metabolic causes, followed by targeted neuropathic pain treatment if confirmed.

Differential Diagnosis Priority

The burning/heat sensation affecting distal extremities (palms and soles) combined with scalp involvement points to:

Primary Considerations:

1. Small Fiber Neuropathy (Most Likely)

  • Diabetic peripheral neuropathy is the leading cause when affecting palms and soles 1, 2, 3
  • Small fiber involvement characteristically produces burning pain and dysesthesias (unpleasant tingling sensations) 1, 4, 3
  • Can present with burning sensations in 84.4% of cases, frequently described as "burning" in 37.4% 5
  • Scalp involvement, while less common, can occur with small fiber polyneuropathy 6, 5

2. Erythromelalgia

  • Presents with burning pain, warmth, and erythema in distal extremities 7, 8
  • Typically affects feet more than hands; scalp involvement would be atypical
  • Episodes are triggered by heat exposure and relieved by cooling 7, 8

3. Scalp Dysesthesia (for scalp component)

  • Neurogenic causes include diabetes, cervical spine disease, small fiber neuropathies 6, 9
  • Can coexist with peripheral neuropathy in diabetic patients 6

Secondary Considerations to Exclude:

  • Vitamin B12 deficiency 1, 2
  • Hypothyroidism 1, 2
  • Alcohol toxicity 1, 2
  • Neurotoxic medications (chemotherapy) 1, 2
  • Renal disease 1, 2
  • HIV infection 2
  • Chronic inflammatory demyelinating neuropathy 2

Recommended Workup Algorithm

Step 1: Initial Screening (All Patients)

Laboratory Tests:

  • Fasting glucose and HbA1c (diabetes screening) 1, 2, 3
  • Vitamin B12 level 1, 2
  • TSH (thyroid function) 1, 2
  • Complete metabolic panel (renal function) 1, 2
  • Complete blood count
  • HIV testing if risk factors present 2

Clinical Examination:

  • Small fiber function testing: pinprick and temperature sensation 1, 2, 3
  • Large fiber function testing: vibration perception using 128-Hz tuning fork 1, 2, 3
  • Protective sensation: 10-g monofilament testing 1, 2, 3
  • Ankle reflexes 10
  • Assess for skin color changes, edema, or erythema in affected areas 5

Step 2: Autonomic Testing (If Initial Tests Suggest Neuropathy)

Screen for autonomic involvement 2, 3:

  • Ask about orthostatic dizziness or syncope
  • Check for orthostatic hypotension (drop in systolic BP >20 mmHg or diastolic >10 mmHg upon standing)
  • Assess for resting tachycardia
  • Examine for dry, cracked skin in extremities 3
  • Inquire about heat intolerance, abnormal sweating 10

Step 3: Specialized Testing (If Diagnosis Unclear)

  • Skin biopsy for intraepidermal nerve fiber density if clinical features are atypical 11, 5
  • Electrophysiological testing only if diagnosis remains unclear after clinical assessment 1, 2, 3
  • Referral to neurology for atypical presentations 1, 2

Treatment Approach

If Diabetic Neuropathy Confirmed:

First Priority: Glycemic Control

  • Optimize glucose management to prevent progression 1, 2, 3
  • Target HbA1c based on individual patient factors

Pharmacologic Treatment for Neuropathic Pain:

Initial therapy (choose one) 1, 2, 4:

  • Pregabalin: 75-300 mg every 12 hours 1, 4
  • Duloxetine: standard dosing 1, 4
  • Gabapentin: starting 300 mg at bedtime, up to 2400 mg daily divided into 3 doses 1, 4, 7

These three medications have Grade A evidence as initial pharmacologic treatments 1, 4.

Alternative agents 10:

  • Amitriptyline, imipramine, or other tricyclic antidepressants
  • Carbamazepine or valproate
  • Tramadol or oxycodone for refractory cases

If Erythromelalgia Suspected:

Topical therapy first-line 7:

  • Compounded amitriptyline-ketamine cream
  • Consider adding clonidine, gabapentin, or lidocaine to topical formulation

Systemic therapy 7:

  • Aspirin for pain relief
  • Sodium channel blockers (mexiletine, carbamazepine)
  • Trial each medication for 3-4 months before switching

Lifestyle modifications 7:

  • Avoid heat triggers
  • Safe cooling methods (limit ice/water immersion to 10 minutes, maximum 4 times daily)

For Scalp Dysesthesia Component:

Topical treatments 6, 9:

  • Topical anesthetics
  • Capsaicin cream (though often not helpful)

Systemic neuropathic pain medications as above 6, 9

Critical Pitfalls to Avoid

  1. Do not assume this is purely dermatologic - burning sensations without visible skin changes strongly suggest neuropathy, not primary skin disease 1, 5

  2. Do not delay diabetes screening - up to 50% of diabetic peripheral neuropathy may be asymptomatic initially, and early symptoms like burning are often the first manifestation 3, 12

  3. Do not order electrophysiological testing routinely - it is rarely needed except when clinical features are atypical or diagnosis is unclear 1, 2, 3

  4. Do not overlook treatable causes - vitamin B12 deficiency, hypothyroidism, and medication toxicity must be excluded as these are reversible 1, 2

  5. Do not miss autonomic involvement - patients with small fiber neuropathy affecting multiple sites (palms, soles, scalp) should be screened for autonomic neuropathy, which affects quality of life and has specific treatments 2, 3

  6. Recognize that normal nerve conduction studies do not exclude small fiber neuropathy - standard electrodiagnostic testing primarily assesses large fiber function 11, 5

References

Research

Cutaneous manifestations of small fibre polyneuropathy.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2022

Research

Scalp dysesthesia: a neuropathic phenomenon.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2022

Guideline

standards of medical care for type 2 diabetes in china 2019.

Diabetes/Metabolism Research and Reviews, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.